<DOC>
	<DOCNO>NCT02669303</DOCNO>
	<brief_summary>The purpose study determine whether injection platelet-rich plasma derive patient 's blood effective treatment shoulder subacromial impingement syndrome compare current protocol methylprednisolone injection .</brief_summary>
	<brief_title>Platelet-rich Plasma ( PRP ) Injection Treating Shoulder Subacromial Impingement Syndrome</brief_title>
	<detailed_description>Patients present shoulder pain study location screen principal investigator . Once diagnose clinically shoulder subacromial impingement syndrome , invite join study . They invite separate academic office explain study , voluntary confidential basis per Institutional Review Board ( IRB ) approve protocol . After sign informed consent form recruitment , assign randomly one study arm software-generated sequential allocation package opaque envelope . All involved except principal investigator patient blind . There two groups/arms study . The experimental arm include subacromial injection study subject autologous platelet-rich plasma ; wheres subject study arm inject methylprednisolone . The outcome assess three score . The study subject ask complete Oxford Shoulder Score questionnaire health-related quality life SF-36 questionnaire Constant-Murley score measure physician-based assessment do resident involve study . This do baseline visit injection repeat 2 , 6 , 12 week 6 month follow-up visit . Also adverse effect treatment arm monitor reported appropriate . The investigator hypothesize inject platelet-rich plasma subacromial space patient subacromial impingement result decrease pain increase function 6 month follow-up ( assessed Constant-Murley Score , Oxford Shoulder Score , Short Form-36 ( SF-36 ) questionnaire ) compare patient inject methylprednisolone .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Shoulder Impingement Syndrome</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Any adult male female 18 65 year age , inclusive , clinical diagnosis shoulder subacromial impingement Age 18 65 year History prior shoulder injection surgery History fracture acromion , clavicle , scapula , proximal humerus Known allergy corticosteroid Known allergy lidocaine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Subacromial injection</keyword>
	<keyword>methylprednisolone</keyword>
	<keyword>treatment</keyword>
	<keyword>Platelet-rich plasma</keyword>
</DOC>